Navigation Links
Diagnosoft(R) Secures $4 Million in Financing and Appoints a New President and CEO
Date:1/29/2009

MORRISVILLE, N.C. and PALO ALTO, Calif., Jan. 29 /PRNewswire/ -- Diagnosoft, Inc., an innovator in magnetic resonance (MR) image analysis software that assists in diagnosis, staging and therapeutic monitoring of cardiovascular disease, has announced the closing of $4 million in Series B financing led by Technology Development Fund (TDF) of Cairo, Egypt. The company intends to use the new capital to support further market expansion of Diagnosoft(R) HARP(TM), Diagnosoft(R) PLUS, and Diagnosoft(R) SENC. The capital infusion will also serve to further the development of other innovative MR image analysis technologies designed to increase physician productivity and accuracy, improve patient outcomes, and enhance research and drug development advances.

"When cardiologists and radiologists can make a decision about the condition of a patient's heart based on quantitative data obtained from cardiac MRI analysis, rather than just 'eyeballing' images," said Diagnosoft Co-Founder Dr. Matthias Stuber, "they can come to a faster conclusion that's substantiated, not subjective. When diagnosis and treatment is supported by the numerical data our software provides, it's stronger from a legal standpoint as well."

According to Dr. Jerry Prince, Diagnosoft co-founder and colleague of Dr. Stuber at Johns Hopkins University, "There are many techniques for analyzing the left ventricle of the heart -- ECHO, nuclear medicine, CT, and so -- but we are focused on the emerging technology of MRI for the cardiac market. We are kind of a one-stop shop for innovative analysis of the four magnetic resonance imaging techniques -- CINE, perfusion, delayed enhancement or viability, and function or strain. Diagnosoft is the only company directly looking at function, to see if the heart muscle is contracting properly; consequently, we are the only ones who can put all four imaging techniques together, and present it to the
'/>"/>

SOURCE Diagnosoft, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. BDSI secures US commercial partnership for BEMA Fentanyl with Meda AB
2. Simplex Diabetic Supply, Inc. Secures $50 Million in Growth Equity from New Enterprise Associates
3. UI licensee Optherion secures $37 million in financing
4. IPS Secures National Contract to Deliver FOCUS Healthcare Provider Network Access to Pain Management Specialists
5. Piedmont Pharmaceuticals Secures $8.5 Million Investment
6. NuView Radiopharmaceuticals, Inc. Secures Exclusive Rights From Thomas Jefferson University for a Tumor-Specific Imaging Agent for the Diagnosis of Breast and Prostate Cancers
7. Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd.
8. Senetek PLC Announces North American Partner for Invicorp(R) Secures Financing for Advancement of Marketing and Development Efforts
9. SpectraScience Secures Distribution for WavSTAT(R) System in Czech Republic
10. InterCure Secures Nationwide Distribution Agreement With Lloyds Pharmacy Group
11. Asoyia Secures Venture Capital Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... While many hospitals have implemented medical ... Civil Rights Act, the unique needs of children with ... light to the value of video remote interpreting (VRI) ... in 20 U.S. children have LEP—a number that rises ... cities.(1) Stratus Video Interpreting enables healthcare providers ...
(Date:3/2/2015)... Doctors in Novara, Italy have found that talc ... for people with mesothelioma than other clinical factors. ... study on the Surviving Mesothelioma website. , Thoracic ... followed the cases of 172 mesothelioma patients ... , “Persistent lung expansion after pleural talc poudrage ...
(Date:3/2/2015)... 02, 2015 Gummy smile reduction ... Gum reshaping can involve one or several procedures to reduce ... gum tissue for a more even gum line. Dr. Farnoosh ... treatment that can permanently lighten discolored or naturally dark ... which involves a personalized treatment plan to address a patient’s ...
(Date:3/2/2015)... SAN ANTONIO (PRWEB) March 02, 2015 ... as quality processes, customer service, pricing and long-term strategy, ... as its vendor of choice for member centers’ testing ... blood centers and represents more than 30 percent of ... recent member meeting. , “BCA is committed to drive ...
(Date:3/2/2015)... New York, New York (PRWEB) March 02, 2015 ... of Creative Recovery at Recovery Unplugged™—will be delivering ... You: A Singer/Songwriter's Perspective on the Art of ... on Addiction Disorders (NCAD) and Behavioral Healthcare Executive ... to his name, Mr. Supa’s songs have been ...
Breaking Medicine News(10 mins):Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 2Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 3Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 4Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2Health News:Gummy Smile Expert, Dr. Alex Farnoosh, is Now Offering Gum Reshaping Procedures 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 3Health News:Richie Supa Announced as a Plenary Speaker at NCAD 2015 2
... Deploys SpringCM Contract Accelerator for, Salesforce.com to Expedite Contract Approval ... ... SAN MATEO, Calif., Feb. 6 SpringCM, the leader ... for Sentinel Health Group, a Colorado-based medical,staffing agency. Since implementing ...
... a medical device company that develops, manufactures and ... dysfunction,announced today that it will be presenting at ... February 20, 2008 at the Ritz Carlton,Laguna Nigel. ... Jiwani,Uroplasty,s Vice President and CFO, will present the ...
... Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood ... the life saving potential of stem cells to families ... in 2007 for,states to legislate that consumers should be ... will continue in 2008 and beyond., New York ...
... common stock was ... $3.81 per share, IRVINE, Calif., ... it received a letter, dated February 4,2008, from The NASDAQ Stock Market, ... bid price of the,Company,s common stock had been below the $1.00 minimum ...
... Taken Together, NORTH ADAMS, Mass., Feb 5 ... globe will join the National,Patient Safety Foundation in ... theme of the week, Patient Safety: A Road ... care through partnership,among providers, patients, families and communities. ...
... endoscopic biopsy methods suggests that a minimally invasive approach ... according to a study in the February 6 issue ... cancer-related cause of death in the United States. Determining ... regarding therapy and prognosis, according to background information in ...
Cached Medicine News:Health News:SpringCM Improves Contract Management Efficiency for Medical Staffing Agency 2Health News:SpringCM Improves Contract Management Efficiency for Medical Staffing Agency 3Health News:Cord Blood America Supports Trend From New York, California for States to Inform Parents of the Advantages of Umbilical Cord Blood Storage 2Health News:IDM Pharma Receives Notification from NASDAQ Relating to Minimum Bid Price 2Health News:Patient Safety Awareness Week March 2 to March 8, 2008 2Health News:Less invasive methods may provide accurate means to determine lung cancer stage 2
(Date:3/2/2015)... Corporation (Nasdaq: DRRX ) announced today financial ... Total revenues were $4.3 million for the three months ... ended December 31, 2013.  Net loss was $5.9 million ... compared to a net loss of $5.1 million for ... and net loss was $22.1 million for the year ...
(Date:3/2/2015)... 2015 Click here for additional information on ... DPLO ), the nation,s largest independent specialty pharmacy, ... 31, 2014. All comparisons, unless otherwise noted, are to the ... Fourth Quarter 2014 Highlights include: , Revenue of ... dispensed of 208,000, an increase of 11% , Gross ...
(Date:3/2/2015)... N.J. , March 2, 2015 BD ... a leading global medical technology company, today announced the ... Diego -based medical technology company dedicated to improving ... acquisition furthers BD,s position in helping address preventable medication ... and CRISI entered into an exclusive partnership in June ...
Breaking Medicine Technology:DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 2DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 3DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 4DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 5DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 6DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 7DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 8DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 9DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 10DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 11DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 12Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 2Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 3Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 4Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 5Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 6Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 7Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 8Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 9Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 10Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 11Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 12Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 13Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 14Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 15Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 16Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 17Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 18Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 19Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 20Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 21BD Acquires CRISI Medical Systems 2BD Acquires CRISI Medical Systems 3
... Reportlinker.com announces that a new market research ... Chinese Pharmaceutical Regulatory Report 2011 ... This report includes a brief ... in China, as well as a discussion ...
... 25, 2011 Reportlinker.com announces that a ... its catalogue: Triple Analysis: ... http://www.reportlinker.com/p0284719/Triple-Analysis-Lymphoma-Prostate-Cancer-and-Antibodies.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology This ... strategies in both Lymphoma and Prostate Cancer ...
Cached Medicine Technology:Reportlinker Adds Chinese Pharmaceutical Regulatory Report 2011 2Reportlinker Adds Triple Analysis: Lymphoma, Prostate Cancer and Antibodies 2Reportlinker Adds Triple Analysis: Lymphoma, Prostate Cancer and Antibodies 3Reportlinker Adds Triple Analysis: Lymphoma, Prostate Cancer and Antibodies 4Reportlinker Adds Triple Analysis: Lymphoma, Prostate Cancer and Antibodies 5
Intended for the quantitative determination of triglycerides in serum or plasma. Reaction: endpoint, reaction is complete in five minutes at 37C. Wavelength: 540 nm. Linearity: 1000 mg/dL (11.3 mmol/...
For the quantitative determination of alkaline phosphatase in human serum....
Auto LDL-Cholesterol, automated analyzer test kits....
Storage temperature: 15 - 30C, linearity: 0 - 20 mg/dL, expected value: male: 3.0 - 7.0 mg/dL and female: 2.2 - 6.2 mg/dL. Available with calibrator and number of tests 125....
Medicine Products: